IOPAMIDOL
| Brand name | ISOVUE-300 |
|---|---|
| Active ingredient | IOPAMIDOL |
| Strength | 61% |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Modality | Small molecule |
| FDA approval | December 1985 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| I-975 | October 2028 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.